Resurrection and Reactivation of Acetylcholinesterase and Butyrylcholinesterase

被引:74
|
作者
Franjesevic, Andrew J. [1 ]
Sillart, Sydney B. [1 ]
Beck, Jeremy M. [1 ]
Vyas, Shubham [1 ,2 ]
Callam, Christopher S. [1 ]
Hadad, Christopher M. [1 ]
机构
[1] Ohio State Univ, Dept Chem & Biochem, 100 West 18th Ave, Columbus, OH 43210 USA
[2] Colorado Sch Mines, Dept Chem, 1500 Illinois St, Golden, CO 80401 USA
基金
美国国家卫生研究院;
关键词
acetylcholinesterase; butyrylcholinesterase; organophosphorus; reactivation; resurrection; INHIBITED HUMAN ACETYLCHOLINESTERASE; IN-VITRO REACTIVATION; RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE; MOLECULAR-DYNAMICS SIMULATION; STRUCTURE-BASED DESIGN; NON-OXIME REACTIVATOR; NERVE AGENT TOXICITY; ACTIVE-SITE GORGE; KINETIC-ANALYSIS; CHOLINESTERASE REACTIVATORS;
D O I
10.1002/chem.201805075
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Organophosphorus (OP) nerve agents and pesticides present significant threats to civilian and military populations. OP compounds include the nefarious G and V chemical nerve agents, but more commonly, civilians are exposed to less toxic OP pesticides, resulting in the same negative toxicological effects and thousands of deaths on an annual basis. After decades of research, no new therapeutics have been realized since the mid-1900s. Upon phosphylation of the catalytic serine residue, a process known as inhibition, there is an accumulation of acetylcholine (ACh) in the brain synapses and neuromuscular junctions, leading to a cholinergic crisis and eventually death. Oxime nucleophiles can reactivate select OP-inhibited acetylcholinesterase (AChE). Yet, the fields of reactivation of AChE and butyrylcholinesterase encounter additional challenges as broad-spectrum reactivation of either enzyme is difficult. Additional problems include the ability to cross the blood brain barrier (BBB) and to provide therapy in the central nervous system. Yet another complication arises in a competitive reaction, known as aging, whereby OP-inhibited AChE is converted to an inactive form, which until very recently, had been impossible to reverse to an active, functional form. Evaluations of uncharged oximes and other neutral nucleophiles have been made. Non-oxime reactivators, such as aromatic general bases and Mannich bases, have been developed. The issue of aging, which generates an anionic phosphylated serine residue, has been historically recalcitrant to recovery by any therapeutic approach-that is, until earlier this year. Mannich bases not only serve as reactivators of OP-inhibited AChE, but this class of compounds can also recover activity from the aged form of AChE, a process referred to as resurrection. This review covers the modern efforts to address all of these issues and notes the complexities of therapeutic development along these different lines of research.
引用
收藏
页码:5337 / 5371
页数:35
相关论文
共 50 条
  • [41] Reactivation of Tabun-inhibited Acetylcholinesterase Investigated by Two Oximes and Mutagenesis
    Katalinic, Maja
    Kovarik, Zrinka
    CROATICA CHEMICA ACTA, 2012, 85 (02) : 209 - 212
  • [42] Discovery of pyrrole derivatives as acetylcholinesterase-sparing butyrylcholinesterase inhibitor
    Sun, Shouyuan
    Shi, Tao
    Peng, Yan
    Zhang, Honghua
    Zhuo, Linsheng
    Peng, Xue
    Li, Qien
    Wang, Manxia
    Wang, Shuzhi
    Wang, Zhen
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [43] Curcumin and its derivatives: Moderate inhibitors of acetylcholinesterase, butyrylcholinesterase and trypsin
    Abbasi, M. A.
    Ilyas, M.
    Aziz-ur-Rehman
    Sonia, A.
    Shahwar, D.
    Raza, M. A.
    Khan, K. M.
    Ashraf, M.
    Afzal, I.
    Ambreen, N.
    SCIENTIA IRANICA, 2012, 19 (06) : 1580 - 1583
  • [44] Determination of acetylcholinesterase and butyrylcholinesterase activity without dilution of biological samples
    Pohanka, Miroslav
    CHEMICAL PAPERS, 2015, 69 (08) : 1044 - 1049
  • [45] Biological, computational evaluation of novel benzofuranyl derivatives as acetylcholinesterase and butyrylcholinesterase
    Usanmaz, Hande
    Tas, Omer
    Ekinci, Deniz
    Uba, Abdullahi Ibrahim
    Atmaca, Ufuk
    FUTURE MEDICINAL CHEMISTRY, 2024, 16 (11) : 1075 - 1085
  • [46] Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions
    Minic, J
    Chatonnet, A
    Krejci, E
    Molgó, J
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (01) : 177 - 187
  • [47] Acetylcholinesterase and Butyrylcholinesterase Inhibitory Compounds from Corydalis cava (Fumariaceae)
    Chlebek, Jakub
    Macakova, Katerina
    Cahlikova, Lucie
    Kurfuerst, Milan
    Kunes, Jiri
    Opletal, Lubomir
    NATURAL PRODUCT COMMUNICATIONS, 2011, 6 (05) : 607 - 610
  • [48] Acetylcholinesterase and Butyrylcholinesterase Inhibitory Compounds from Chelidonium majus (Papaveraceae)
    Cahlikova, Lucie
    Opletal, Lubomir
    Kurfurst, Milan
    Macakova, Katerina
    Kulhankova, Andrea
    Host'alkova, Anna
    NATURAL PRODUCT COMMUNICATIONS, 2010, 5 (11) : 1751 - 1754
  • [49] Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plants
    Orhan, I
    Sener, B
    Choudhary, MI
    Khalid, A
    JOURNAL OF ETHNOPHARMACOLOGY, 2004, 91 (01) : 57 - 60
  • [50] INVESTIGATION OF INHIBITORY EFFECT OF HUMIC ACID ON ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE ENZYMES
    Akincioglu, Hulya
    Gulcin, Ilhami
    Alwasel, Saleh H.
    FRESENIUS ENVIRONMENTAL BULLETIN, 2017, 26 (06): : 3733 - 3739